HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) Fundamental Analysis & Valuation

NYSE:HCXY • US4270968476

25.25 USD
-0.05 (-0.2%)
Last: Mar 13, 2026, 10:40 AM

This HCXY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, HCXY scores 4 out of 10 in our fundamental rating. HCXY was compared to 242 industry peers in the Capital Markets industry. While HCXY is still in line with the averages on profitability rating, there are concerns on its financial health. HCXY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. HCXY Profitability Analysis

1.1 Basic Checks

  • In the past year HCXY was profitable.
  • HCXY had a negative operating cash flow in the past year.
  • In the past 5 years HCXY has always been profitable.
  • In multiple years HCXY reported negative operating cash flow during the last 5 years.
HCXY Yearly Net Income VS EBIT VS OCF VS FCFHCXY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • With a decent Return On Assets value of 7.35%, HCXY is doing good in the industry, outperforming 77.27% of the companies in the same industry.
  • HCXY has a better Return On Equity (15.20%) than 75.62% of its industry peers.
  • The Return On Invested Capital of HCXY (6.00%) is better than 75.21% of its industry peers.
  • HCXY had an Average Return On Invested Capital over the past 3 years of 6.67%. This is in line with the industry average of 7.06%.
Industry RankSector Rank
ROA 7.35%
ROE 15.2%
ROIC 6%
ROA(3y)7.97%
ROA(5y)6.77%
ROE(3y)15.61%
ROE(5y)13.42%
ROIC(3y)6.67%
ROIC(5y)5.93%
HCXY Yearly ROA, ROE, ROICHCXY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • HCXY has a better Profit Margin (63.24%) than 93.39% of its industry peers.
  • HCXY's Profit Margin has declined in the last couple of years.
  • HCXY has a Operating Margin of 64.17%. This is amongst the best in the industry. HCXY outperforms 96.28% of its industry peers.
  • In the last couple of years the Operating Margin of HCXY has grown nicely.
  • Looking at the Gross Margin, with a value of 80.62%, HCXY belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HCXY has remained more or less at the same level.
Industry RankSector Rank
OM 64.17%
PM (TTM) 63.24%
GM 80.62%
OM growth 3Y3.15%
OM growth 5Y3.25%
PM growth 3Y26.79%
PM growth 5Y-4.23%
GM growth 3Y0.01%
GM growth 5Y1%
HCXY Yearly Profit, Operating, Gross MarginsHCXY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

2

2. HCXY Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for HCXY has been increased compared to 1 year ago.
  • HCXY has more shares outstanding than it did 5 years ago.
  • HCXY has a worse debt/assets ratio than last year.
HCXY Yearly Shares OutstandingHCXY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HCXY Yearly Total Debt VS Total AssetsHCXY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • HCXY has an Altman-Z score of 1.57. This is a bad value and indicates that HCXY is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.57, HCXY is in the better half of the industry, outperforming 65.70% of the companies in the same industry.
  • HCXY has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • HCXY has a Debt to Equity ratio of 1.03. This is comparable to the rest of the industry: HCXY outperforms 49.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACCN/A
WACCN/A
HCXY Yearly LT Debt VS Equity VS FCFHCXY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • HCXY has a Current Ratio of 1.16. This is a normal value and indicates that HCXY is financially healthy and should not expect problems in meeting its short term obligations.
  • HCXY has a Current ratio (1.16) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.16 indicates that HCXY should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.16, HCXY is in line with its industry, outperforming 53.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HCXY Yearly Current Assets VS Current LiabilitesHCXY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

3

3. HCXY Growth Analysis

3.1 Past

  • HCXY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.48%.
  • HCXY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.52% yearly.
  • HCXY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.44%.
  • HCXY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)-4.48%
EPS 3Y9.06%
EPS 5Y6.52%
EPS Q2Q%-2.04%
Revenue 1Y (TTM)-13.44%
Revenue growth 3Y18.29%
Revenue growth 5Y13.13%
Sales Q2Q%12.85%

3.2 Future

  • Based on estimates for the next years, HCXY will show a decrease in Earnings Per Share. The EPS will decrease by -0.22% on average per year.
  • Based on estimates for the next years, HCXY will show a small growth in Revenue. The Revenue will grow by 6.72% on average per year.
EPS Next Y5.31%
EPS Next 2Y3.42%
EPS Next 3Y-0.22%
EPS Next 5YN/A
Revenue Next Year8.54%
Revenue Next 2Y6.54%
Revenue Next 3Y6.72%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HCXY Yearly Revenue VS EstimatesHCXY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
HCXY Yearly EPS VS EstimatesHCXY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

3

4. HCXY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.15, the valuation of HCXY can be described as correct.
  • HCXY's Price/Earnings is on the same level as the industry average.
  • HCXY is valuated rather cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • HCXY is valuated correctly with a Price/Forward Earnings ratio of 12.49.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HCXY.
  • When comparing the Price/Forward Earnings ratio of HCXY to the average of the S&P500 Index (23.82), we can say HCXY is valued slightly cheaper.
Industry RankSector Rank
PE 13.15
Fwd PE 12.49
HCXY Price Earnings VS Forward Price EarningsHCXY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HCXY is valued a bit cheaper than 68.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.11
HCXY Per share dataHCXY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HCXY does not grow enough to justify the current Price/Earnings ratio.
  • HCXY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)2.02
EPS Next 2Y3.42%
EPS Next 3Y-0.22%

5

5. HCXY Dividend Analysis

5.1 Amount

  • HCXY has a Yearly Dividend Yield of 10.59%, which is a nice return.
  • HCXY's Dividend Yield is a higher than the industry average which is at 6.63.
  • HCXY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 10.59%

5.2 History

  • On average, the dividend of HCXY grows each year by 6.10%, which is quite nice.
  • HCXY has been paying a dividend for over 5 years, so it has already some track record.
  • HCXY has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.1%
Div Incr Years0
Div Non Decr Years2
HCXY Yearly Dividends per shareHCXY Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 96.80% of the earnings are spent on dividend by HCXY. This is not a sustainable payout ratio.
  • HCXY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP96.8%
EPS Next 2Y3.42%
EPS Next 3Y-0.22%
HCXY Yearly Income VS Free CF VS DividendHCXY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M
HCXY Dividend Payout.HCXY Dividend Payout, showing the Payout Ratio.HCXY Dividend Payout.PayoutRetained Earnings

HCXY Fundamentals: All Metrics, Ratios and Statistics

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33

NYSE:HCXY (3/13/2026, 10:40:48 AM)

25.25

-0.05 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap4.64B
Revenue(TTM)532.49M
Net Income(TTM)336.77M
Analysts82.67
Price Target34.93 (38.34%)
Short Float %0%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 10.59%
Yearly Dividend1.85
Dividend Growth(5Y)6.1%
DP96.8%
Div Incr Years0
Div Non Decr Years2
Ex-Date01-15
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.03%
Min EPS beat(2)-4.39%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-1.26%
Min EPS beat(4)-5.01%
Max EPS beat(4)4.02%
EPS beat(8)2
Avg EPS beat(8)-1.97%
EPS beat(12)6
Avg EPS beat(12)0.56%
EPS beat(16)8
Avg EPS beat(16)0.88%
Revenue beat(2)1
Avg Revenue beat(2)-1.37%
Min Revenue beat(2)-2.99%
Max Revenue beat(2)0.25%
Revenue beat(4)2
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-4.12%
Max Revenue beat(4)3.19%
Revenue beat(8)3
Avg Revenue beat(8)-1.82%
Revenue beat(12)7
Avg Revenue beat(12)3.76%
Revenue beat(16)9
Avg Revenue beat(16)2.91%
PT rev (1m)18.8%
PT rev (3m)12.79%
EPS NQ rev (1m)-2.89%
EPS NQ rev (3m)-3.13%
EPS NY rev (1m)-1.76%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 13.15
Fwd PE 12.49
P/S 8.71
P/FCF N/A
P/OCF N/A
P/B 2.09
P/tB 2.09
EV/EBITDA 20.11
EPS(TTM)1.92
EY7.6%
EPS(NY)2.02
Fwd EY8.01%
FCF(TTM)-2.32
FCFYN/A
OCF(TTM)-2.32
OCFYN/A
SpS2.9
BVpS12.06
TBVpS12.06
PEG (NY)2.48
PEG (5Y)2.02
Graham Number22.83
Profitability
Industry RankSector Rank
ROA 7.35%
ROE 15.2%
ROCE 7.59%
ROIC 6%
ROICexc 6.07%
ROICexgc 6.08%
OM 64.17%
PM (TTM) 63.24%
GM 80.62%
FCFM N/A
ROA(3y)7.97%
ROA(5y)6.77%
ROE(3y)15.61%
ROE(5y)13.42%
ROIC(3y)6.67%
ROIC(5y)5.93%
ROICexc(3y)6.83%
ROICexc(5y)6.09%
ROICexgc(3y)6.85%
ROICexgc(5y)6.1%
ROCE(3y)8.44%
ROCE(5y)7.51%
ROICexgc growth 3Y6.57%
ROICexgc growth 5Y3.09%
ROICexc growth 3Y6.55%
ROICexc growth 5Y3.09%
OM growth 3Y3.15%
OM growth 5Y3.25%
PM growth 3Y26.79%
PM growth 5Y-4.23%
GM growth 3Y0.01%
GM growth 5Y1%
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA 6.68
Cap/Depr 26.41%
Cap/Sales 0.02%
Interest Coverage 4.09
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.57
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)214.85%
Cap/Depr(5y)145.57%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.48%
EPS 3Y9.06%
EPS 5Y6.52%
EPS Q2Q%-2.04%
EPS Next Y5.31%
EPS Next 2Y3.42%
EPS Next 3Y-0.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.44%
Revenue growth 3Y18.29%
Revenue growth 5Y13.13%
Sales Q2Q%12.85%
Revenue Next Year8.54%
Revenue Next 2Y6.54%
Revenue Next 3Y6.72%
Revenue Next 5YN/A
EBIT growth 1Y-15.62%
EBIT growth 3Y22.02%
EBIT growth 5Y16.82%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-258.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-260.58%
OCF growth 3YN/A
OCF growth 5YN/A

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 / HCXY FAQ

Can you provide the ChartMill fundamental rating for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33?

ChartMill assigns a fundamental rating of 4 / 10 to HCXY.


What is the valuation status of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) stock?

ChartMill assigns a valuation rating of 3 / 10 to HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY). This can be considered as Overvalued.


Can you provide the profitability details for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33?

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) has a profitability rating of 6 / 10.


Can you provide the financial health for HCXY stock?

The financial health rating of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) is 2 / 10.


What is the expected EPS growth for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) stock?

The Earnings per Share (EPS) of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) is expected to grow by 5.31% in the next year.